{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:50:55Z","timestamp":1777780255790,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H28-Shinkou-Ippan-003"],"award-info":[{"award-number":["H28-Shinkou-Ippan-003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jiac.2019.07.022","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:51:06Z","timestamp":1566521466000},"page":"95-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between cytopenia and gestational age in infants and neonates treated with linezolid therapy"],"prefix":"10.1016","volume":"26","author":[{"given":"Yuichi","family":"Shibata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-209X","authenticated-orcid":false,"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-8767","authenticated-orcid":false,"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.07.022_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1067\/mpd.2001.119442","article-title":"Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey","volume":"139","author":"Sohn","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2019.07.022_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006454-200001000-00012","article-title":"Occurrence of nosocomial bloodstream infections in six neonatal intensive care units","volume":"19","author":"Brodie","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2019.07.022_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/peds.103.4.e39","article-title":"Gaynes RP, and the national nosocomial infections surveillance system. Nosocomial infections in pediatric intensive care units in the United States","volume":"103","author":"Richards","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2019.07.022_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1542\/peds.110.4.e42","article-title":"Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices","volume":"110","author":"Rubin","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2019.07.022_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1381612802666220921173820","article-title":"Oxazolidinone antibacterial agents","volume":"2","author":"Brickner","year":"1996","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jiac.2019.07.022_bib6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.40.7.1745","article-title":"In\u00a0vitro activities of new oxazolidinone, antimicrobial agents against enterococci","volume":"40","author":"Eliopoulos","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.07.022_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","article-title":"In\u00a0vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents","volume":"40","author":"Zurenko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.07.022_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/AAC.41.2.465","article-title":"In\u00a0vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative staphylococcus species","volume":"41","author":"Jorgensen","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.07.022_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/j.1875-9114.1998.tb03109.x","article-title":"The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials","volume":"18","author":"Dresser","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2019.07.022_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.42.3.721","volume":"42","author":"Rybak","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.07.022_bib11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.07.022_bib12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/00006454-200012000-00012","article-title":"Single dose pharmacokinetics of linezolid in infants and children","volume":"19","author":"Kearns","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2019.07.022_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00006454-200105000-00004","article-title":"Linezolid for the treatment of community-acquired pneumonia in hospitalized children","volume":"20","author":"Kaplan","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2019.07.022_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.inf.0000059403.21440.2c","article-title":"Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children","volume":"22","author":"Wible","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2019.07.022_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.inf.0000078160.29072.42","article-title":"Linezolid versus vancomycin in the treatment of resistant Gram-positive infections in children","volume":"22","author":"Kaplan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2019.07.022_bib16","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.07.022_bib17","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0149-2918(03)80118-2","article-title":"Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia","volume":"25","author":"Wunderink","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2019.07.022_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jiac.2018.04.006","article-title":"Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections","volume":"24","author":"Shibata","year":"2018","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.07.022_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00128072-200305060-00009","article-title":"Linezolid: in infants and children with severe Gram-positive infections","volume":"5","author":"Lyseng-Williamson","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jiac.2019.07.022_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00003495-200161040-00008","article-title":"Linezolid: a review of its use in the management of serious gram-positive infections","volume":"61","author":"Perry","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2019.07.022_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/498509","article-title":"High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease","volume":"42","author":"Wu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.07.022_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijantimicag.2008.07.002","article-title":"Renal function as a predictor of linezolid-induced thrombocytopenia","volume":"33","author":"Matsumoto","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2019.07.022_bib23","series-title":"Zyvox (linezolid) prescribing information","year":"2012"},{"key":"10.1016\/j.jiac.2019.07.022_bib24","first-page":"137","article-title":"Pharmacokinetics of linezolid in patients with severe renal insufficiency","volume":"26","author":"Yamazaki","year":"2009","journal-title":"Japanese J Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jiac.2019.07.022_bib25","first-page":"2091","article-title":"Histological study of the fetal kidneys. Development of the nephrons according to gestational weeks","volume":"84","author":"Shimada","year":"1993","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"10.1016\/j.jiac.2019.07.022_bib26","first-page":"9","article-title":"Long-term renal follow-up of preterm neonates born before 35 weeks of gestation","volume":"30","author":"Horie","year":"2017","journal-title":"Jpn J Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.jiac.2019.07.022_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jiac.2015.06.007","article-title":"Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy","volume":"21","author":"Kato","year":"2015","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19302338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19302338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:32Z","timestamp":1761159572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19302338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1341321X19302338"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.07.022","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between cytopenia and gestational age in infants and neonates treated with linezolid therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}